About this episode
In this episode of Fat Science , hosts Dr. Emily Cooper, Andrea Taylor, and Mark Wright explore the compelling and urgent topic of COVID-19's impact on metabolic health. COVID-19 has introduced a serious new layer of complexity because it can exacerbate existing conditions like diabetes, obesity, cardiovascular and thyroid disease. The latest data reveal a shocking statistic—the risk of developing diabetes can increase by up to 40 percent after a COVID infection. So what should we know about these risks, and how can scientific insight help us navigate this new terrain? Key Discussion Points: Early Data and Predictions: Insights from Dr. Cooper's clinic, supported by the Diabesity Institute, which identified early links between COVID-19 and metabolic disease risk. Real-World Impacts: The clinic’s database comprising around 2,500 patients with more than 10 years of data, which showcases the regression of metabolic health progress post-pandemic. Public Health: The importance of vaccinations, continuous COVID monitoring, and preventive practices to mitigate these risks. Metabolic Meds: The role of medications like Metformin and Ozempic in managing complications from pre-diabetes and diabetes, particularly during COVID. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn . Connect with Andrea Taylor on Instagram . Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope. Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org .